|Bid||80.91 x 800|
|Ask||82.84 x 800|
|Day's Range||81.36 - 84.25|
|52 Week Range||65.22 - 88.76|
|Beta (3Y Monthly)||0.81|
|PE Ratio (TTM)||50.39|
|Earnings Date||Oct 15, 2019 - Oct 21, 2019|
|Forward Dividend & Yield||1.28 (1.52%)|
|1y Target Est||94.32|
Robust domestic sales along with a strong unveiling of the t:slim X2 Insulin Pump in the international markets augur well for Tandem Diabetes (TNDM).
With the FDA's expanded indication nod, Medtronic's (MDT) Evolut TAVR platform now comes in handy for treating symptomatic severe aortic stenosis patients across all risk categories.
- Agreement gives law enforcement access to the most advanced handheld tools to help detect drug and alcohol-impaired drivers - Collaboration is a major step in keeping roads safer as recreational marijuana ...
Zacks.com featured highlights include: Abbott Laboratories, Baxter International, First Horizon National, OUTFRONT Media and ICF International
Investors target stocks that have been on a bullish run lately. Stocks seeing price strength have a high chance of carrying the momentum forward.
Executive Vice President & CFO of Abbott Laboratories (30-Year Financial, Insider Trades) Brian B Yoor (insider trades) sold 43,763 shares of ABT on 08/08/2019 at an average price of $85.77 a share. Continue reading...
A look at the shareholders of Abbott Laboratories (NYSE:ABT) can tell us which group is most powerful. Institutions...
Jason Smerdon invests his retirement portfolio in aggressive growth funds and factors in environmental concerns only when investing in individual stocks.
Abbott is leasing the first office building at the Seven Oaks project that’s currently under construction on Bee Caves Road.
The top 50 stockholdings of mutual funds and hedge funds, whose investment approaches typically differ, have a near-record degree of similarity, according to a study by Bank of America Merrill Lynch. "This huge world of investible assets has shrunk down to a small cohort,” observes Savita Subramanian, head of U.S. equity quantitative strategy at BofAML. The trend was detailed in a story by The Wall Street Journal as outlined below.